APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pirfenidone Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pirfenidone Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025181 pages

Choose your research edition.

Industry ResearchPirfenidone Drugs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Pirfenidone Drugs Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Pirfenidone Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pirfenidone Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Pirfenidone Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pirfenidone Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pirfenidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pirfenidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pirfenidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pirfenidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pirfenidone Drugs include Teva, Sandoz, Roche, Kawin, Gyre Pharmaceuticals, ScieGen Pharmaceuticals, Apotex, Amneal Pharmaceuticals and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pirfenidone Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pirfenidone Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pirfenidone Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pirfenidone Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Pirfenidone Drugs Segment by Company

Teva

Sandoz

Roche

Kawin

Gyre Pharmaceuticals

ScieGen Pharmaceuticals

Apotex

Amneal Pharmaceuticals

Accord Healthcare

Pirfenidone Drugs Segment by Type

Capsules

Tablets

Pirfenidone Drugs Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Pirfenidone Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pirfenidone Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pirfenidone Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pirfenidone Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pirfenidone Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pirfenidone Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pirfenidone Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pirfenidone Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pirfenidone Drugs Industry Trends Table 2. Pirfenidone Drugs Industry Drivers Table 3. Pirfenidone Drugs Industry Opportunities and Challenges Table 4. Pirfenidone Drugs Industry Restraints Table 5. Global Pirfenidone Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pirfenidone Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pirfenidone Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Pirfenidone Drugs Sales Market Share by Manufacturers Table 9. Global Pirfenidone Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Pirfenidone Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pirfenidone Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pirfenidone Drugs Manufacturers, Product Type & Application Table 13. Global Pirfenidone Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pirfenidone Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Capsules Table 17. Major Manufacturers of Tablets Table 18. Global Pirfenidone Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Pirfenidone Drugs Sales by Type (2021-2026) & (k units) Table 20. Global Pirfenidone Drugs Sales by Type (2027-2032) & (k units) Table 21. Global Pirfenidone Drugs Sales Market Share by Type (2021-2026) Table 22. Global Pirfenidone Drugs Sales Market Share by Type (2027-2032) Table 23. Global Pirfenidone Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Pirfenidone Drugs Revenue by Type (2021-2026) & (k units) Table 25. Global Pirfenidone Drugs Revenue by Type (2027-2032) & (k units) Table 26. Global Pirfenidone Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Pirfenidone Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital and Clinic Table 29. Major Manufacturers of Retail Pharmacies Table 30. Major Manufacturers of Other Table 31. Global Pirfenidone Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Pirfenidone Drugs Sales by Application (2021-2026) & (k units) Table 33. Global Pirfenidone Drugs Sales by Application (2027-2032) & (k units) Table 34. Global Pirfenidone Drugs Sales Market Share by Application (2021-2026) Table 35. Global Pirfenidone Drugs Sales Market Share by Application (2027-2032) Table 36. Global Pirfenidone Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Pirfenidone Drugs Revenue by Application (2021-2026) & (k units) Table 38. Global Pirfenidone Drugs Revenue by Application (2027-2032) & (k units) Table 39. Global Pirfenidone Drugs Revenue Market Share by Application (2021-2026) Table 40. Global Pirfenidone Drugs Revenue Market Share by Application (2027-2032) Table 41. Global Pirfenidone Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Pirfenidone Drugs Sales by Region (2021-2026) & (k units) Table 43. Global Pirfenidone Drugs Sales Market Share by Region (2021-2026) Table 44. Global Pirfenidone Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Pirfenidone Drugs Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Pirfenidone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Pirfenidone Drugs Sales by Country (2021-2026) & (k units) Table 48. North America Pirfenidone Drugs Sales by Country (2027-2032) & (k units) Table 49. Europe Pirfenidone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Pirfenidone Drugs Sales by Country (2021-2026) & (k units) Table 51. Europe Pirfenidone Drugs Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Pirfenidone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Pirfenidone Drugs Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Pirfenidone Drugs Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Pirfenidone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Pirfenidone Drugs Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Pirfenidone Drugs Sales by Country (2027-2032) & (k units) Table 58. Global Pirfenidone Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Pirfenidone Drugs Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Pirfenidone Drugs Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Pirfenidone Drugs Revenue Market Share by Region (2021-2026) Table 62. Global Pirfenidone Drugs Revenue Market Share by Region (2027-2032) Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Pirfenidone Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva Pirfenidone Drugs Product Portfolio Table 67. Teva Recent Development Table 68. Sandoz Company Information Table 69. Sandoz Business Overview Table 70. Sandoz Pirfenidone Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sandoz Pirfenidone Drugs Product Portfolio Table 72. Sandoz Recent Development Table 73. Roche Company Information Table 74. Roche Business Overview Table 75. Roche Pirfenidone Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Roche Pirfenidone Drugs Product Portfolio Table 77. Roche Recent Development Table 78. Kawin Company Information Table 79. Kawin Business Overview Table 80. Kawin Pirfenidone Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Kawin Pirfenidone Drugs Product Portfolio Table 82. Kawin Recent Development Table 83. Gyre Pharmaceuticals Company Information Table 84. Gyre Pharmaceuticals Business Overview Table 85. Gyre Pharmaceuticals Pirfenidone Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Gyre Pharmaceuticals Pirfenidone Drugs Product Portfolio Table 87. Gyre Pharmaceuticals Recent Development Table 88. ScieGen Pharmaceuticals Company Information Table 89. ScieGen Pharmaceuticals Business Overview Table 90. ScieGen Pharmaceuticals Pirfenidone Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. ScieGen Pharmaceuticals Pirfenidone Drugs Product Portfolio Table 92. ScieGen Pharmaceuticals Recent Development Table 93. Apotex Company Information Table 94. Apotex Business Overview Table 95. Apotex Pirfenidone Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Apotex Pirfenidone Drugs Product Portfolio Table 97. Apotex Recent Development Table 98. Amneal Pharmaceuticals Company Information Table 99. Amneal Pharmaceuticals Business Overview Table 100. Amneal Pharmaceuticals Pirfenidone Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Amneal Pharmaceuticals Pirfenidone Drugs Product Portfolio Table 102. Amneal Pharmaceuticals Recent Development Table 103. Accord Healthcare Company Information Table 104. Accord Healthcare Business Overview Table 105. Accord Healthcare Pirfenidone Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Accord Healthcare Pirfenidone Drugs Product Portfolio Table 107. Accord Healthcare Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Pirfenidone Drugs Distributors List Table 111. Pirfenidone Drugs Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Pirfenidone Drugs Product Image Figure 2. Global Pirfenidone Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pirfenidone Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Pirfenidone Drugs Sales (2021-2032) & (k units) Figure 5. Global Pirfenidone Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pirfenidone Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Capsules Image Figure 9. Tablets Image Figure 10. Global Pirfenidone Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Pirfenidone Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pirfenidone Drugs Sales Market Share by Type (2021-2032) Figure 13. Global Pirfenidone Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Pirfenidone Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pirfenidone Drugs Revenue Market Share by Type (2021-2032) Figure 16. Hospital and Clinic Image Figure 17. Retail Pharmacies Image Figure 18. Other Image Figure 19. Global Pirfenidone Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Pirfenidone Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Pirfenidone Drugs Sales Market Share by Application (2021-2032) Figure 22. Global Pirfenidone Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Pirfenidone Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Pirfenidone Drugs Revenue Market Share by Application (2021-2032) Figure 25. North America Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Pirfenidone Drugs Sales Market Share by Country (2021-2032) Figure 27. U.S. Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Pirfenidone Drugs Sales Market Share by Country (2021-2032) Figure 32. Germany Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Pirfenidone Drugs Sales Market Share by Country (2021-2032) Figure 39. China Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Pirfenidone Drugs Sales Market Share by Country (2021-2032) Figure 47. Brazil Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Pirfenidone Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Pirfenidone Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Pirfenidone Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Pirfenidone Drugs Revenue (2021-2032) & (US$ Million) Figure 58. North America Pirfenidone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Pirfenidone Drugs Revenue (2021-2032) & (US$ Million) Figure 60. Europe Pirfenidone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Pirfenidone Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Pirfenidone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Pirfenidone Drugs Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Pirfenidone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Pirfenidone Drugs Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Pirfenidone Drugs Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Tablets
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Teva
  • Sandoz
  • Roche
  • Kawin
  • Gyre Pharmaceuticals
  • ScieGen Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pirfenidone Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pirfenidone Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pirfenidone Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pirfenidone Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pirfenidone Drugs Market Dynamics
  1. 2.1 Pirfenidone Drugs Industry Trends
  2. 2.2 Pirfenidone Drugs Industry Drivers
  3. 2.3 Pirfenidone Drugs Industry Opportunities and Challenges
  4. 2.4 Pirfenidone Drugs Industry Restraints
3 Pirfenidone Drugs Market by Manufacturers
  1. 3.1 Global Pirfenidone Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pirfenidone Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pirfenidone Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pirfenidone Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pirfenidone Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pirfenidone Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Pirfenidone Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pirfenidone Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pirfenidone Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pirfenidone Drugs Tier 1, Tier 2, and Tier 3
4 Pirfenidone Drugs Market by Type
  1. 4.1 Pirfenidone Drugs Type Introduction
  2. 4.1.1 Capsules
  3. 4.1.2 Tablets
  4. 4.2 Global Pirfenidone Drugs Sales by Type
  5. 4.2.1 Global Pirfenidone Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pirfenidone Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global Pirfenidone Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pirfenidone Drugs Revenue by Type
  9. 4.3.1 Global Pirfenidone Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pirfenidone Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global Pirfenidone Drugs Revenue Market Share by Type (2021-2032)
5 Pirfenidone Drugs Market by Application
  1. 5.1 Pirfenidone Drugs Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Pirfenidone Drugs Sales by Application
  6. 5.2.1 Global Pirfenidone Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pirfenidone Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Pirfenidone Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pirfenidone Drugs Revenue by Application
  10. 5.3.1 Global Pirfenidone Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pirfenidone Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Pirfenidone Drugs Revenue Market Share by Application (2021-2032)
6 Global Pirfenidone Drugs Sales by Region
  1. 6.1 Global Pirfenidone Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pirfenidone Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Pirfenidone Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Pirfenidone Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pirfenidone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pirfenidone Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pirfenidone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pirfenidone Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pirfenidone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pirfenidone Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pirfenidone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pirfenidone Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pirfenidone Drugs Revenue by Region
  1. 7.1 Global Pirfenidone Drugs Revenue by Region
  2. 7.1.1 Global Pirfenidone Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pirfenidone Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Pirfenidone Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Pirfenidone Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pirfenidone Drugs Revenue (2021-2032)
  8. 7.2.2 North America Pirfenidone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pirfenidone Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Pirfenidone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pirfenidone Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pirfenidone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pirfenidone Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pirfenidone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Pirfenidone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pirfenidone Drugs Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Pirfenidone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Pirfenidone Drugs Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche Pirfenidone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche Pirfenidone Drugs Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Kawin
  20. 8.4.1 Kawin Company Information
  21. 8.4.2 Kawin Business Overview
  22. 8.4.3 Kawin Pirfenidone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kawin Pirfenidone Drugs Product Portfolio
  24. 8.4.5 Kawin Recent Developments
  25. 8.5 Gyre Pharmaceuticals
  26. 8.5.1 Gyre Pharmaceuticals Company Information
  27. 8.5.2 Gyre Pharmaceuticals Business Overview
  28. 8.5.3 Gyre Pharmaceuticals Pirfenidone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Gyre Pharmaceuticals Pirfenidone Drugs Product Portfolio
  30. 8.5.5 Gyre Pharmaceuticals Recent Developments
  31. 8.6 ScieGen Pharmaceuticals
  32. 8.6.1 ScieGen Pharmaceuticals Company Information
  33. 8.6.2 ScieGen Pharmaceuticals Business Overview
  34. 8.6.3 ScieGen Pharmaceuticals Pirfenidone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ScieGen Pharmaceuticals Pirfenidone Drugs Product Portfolio
  36. 8.6.5 ScieGen Pharmaceuticals Recent Developments
  37. 8.7 Apotex
  38. 8.7.1 Apotex Company Information
  39. 8.7.2 Apotex Business Overview
  40. 8.7.3 Apotex Pirfenidone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Apotex Pirfenidone Drugs Product Portfolio
  42. 8.7.5 Apotex Recent Developments
  43. 8.8 Amneal Pharmaceuticals
  44. 8.8.1 Amneal Pharmaceuticals Company Information
  45. 8.8.2 Amneal Pharmaceuticals Business Overview
  46. 8.8.3 Amneal Pharmaceuticals Pirfenidone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Amneal Pharmaceuticals Pirfenidone Drugs Product Portfolio
  48. 8.8.5 Amneal Pharmaceuticals Recent Developments
  49. 8.9 Accord Healthcare
  50. 8.9.1 Accord Healthcare Company Information
  51. 8.9.2 Accord Healthcare Business Overview
  52. 8.9.3 Accord Healthcare Pirfenidone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Accord Healthcare Pirfenidone Drugs Product Portfolio
  54. 8.9.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pirfenidone Drugs Value Chain Analysis
  2. 9.1.1 Pirfenidone Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pirfenidone Drugs Production Mode & Process
  6. 9.2 Pirfenidone Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pirfenidone Drugs Distributors
  9. 9.2.3 Pirfenidone Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst